Introduction
Tanvex Biologics is a leading biologics research and development company in Taiwan. With over 10 years of experience in mAb-related cancer drug development, Tanvex is fully committed to using its extensive experience in non-GMP pilot production with partners from all over the globe.
* Track record:
1. Biosimilar (see www.tanvex.com for pipeline)
2. Novel biologics
- Antibody-drug conjugates (ADC)
- Nanoparticle
- Immunocytokines (ImC)
- Bispecific antibody (BsAb)
More about the capability of Tanvex's CDMO:
* Non-GMP development in Taiwan: www.tanvexbiologics.com.tw
* GMP manufacturing in USA: tanvexcdmo.com
Features / strengths
R&D Expertise:
- Develop the scalable, stable & marketable cell lines with innovative engineering processes
- Provide smart solutions for the design and scale-up of purification and formulation
- Offer high yield rate during up-and down-stream production
- Fulfill the customized development and validation of human cell-based bioassays
- Build up the comprehensively ICH-matched analyses of bulk drugs
- Support the GMP-aligned pilot production to meet the ICH requirements for non-clinical and clinical investigations
Specification in detail
Manufacturing site
nonGMP in Taiwan, GMP in USA
Expression system
microbial, mammalian
